comparemela.com

Latest Breaking News On - Caroline robert - Page 4 : comparemela.com

Novel Drug, First Tx for Rare Uveal Melanoma

A novel drug, the first in its class, is also the first treatment approved for use in uveal melanoma, a rare cancer of the eye, after it was shown to improve overall survival.

France generalUnited statesUnited kingdomBaden wübergJohn kirkwoodJessica hasselGustave roussyCaroline robertMelanoma centerUniversity hospital heidelbergDrug administrationAmerican association of cancer researchRegulatory agencyAustralian therapeutic goods administrationSaclay universityHealth canada

Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

/PRNewswire/ Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today.

United statesGil feilerInstagram cannabicsNoam shomronAmos torenDana benErez scapaFacebook cannabicspharmaceuticalsCaroline robertSigalit arieli portnoyZamir halpernCompany on twitter cannabicsMinistry of healthCompany scientific advisory board memberCompany ip portfolioExchange commission

Radiation Oncology Expert Joins Cannabics Pharmaceuticals Board of Advisors

/PRNewswire/ Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today.

United statesGil feilerInstagram cannabicsNoam shomronAmos torenDana benYonina tovaErez scapaFacebook cannabicspharmaceuticalsCaroline robertSigalit arieli portnoyZamir halpernCompany on twitter cannabicsMinistry of healthCompany ip portfolioExchange commission

EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today.

Gil feilerInstagram cannabicsNoam shomronAmos torenDana benErez scapaFacebook cannabicspharmaceuticalsCaroline robertSigalit arieli portnoyZamir halpernCompany on twitter cannabicsMinistry of healthCompany ip portfolioExchange commissionCannabics pharmaceuticalsGroup quickview

CNBX Director, Dr Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas

/PRNewswire/ Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today.

Gil feilerInstagram cannabicsNoam shomronLas vegasAmos torenDana benErez scapaFacebook cannabicspharmaceuticalsCaroline robertSigalit arieli portnoyInbar maymon pomeranchikZamir halpernRegulatory panel sessionCompany on twitter cannabicsMinistry of healthCompany ip portfolio

vimarsana © 2020. All Rights Reserved.